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A B S T R A C T
Background: Wolfram syndrome (WS), caused by mutations in WFS1 gene, is a
multi-targeting disease affecting multiple organ systems. Wolframin is localized in the membrane of the endoplasmic reticulum (ER), influencing Ca2+ metabolism
and ER interaction with mitochondria, but the exact role of the protein remains unclear. In this study we aimed to characterize alterations in energy metabolism in
the cardiac and in the oxidative and glycolytic skeletal muscles in Wfs1-deficiency.
Methods: Alterations in the bioenergetic profiles in the cardiac and skeletal muscles of Wfs1-knock-out (KO) male mice and their wild type male littermates were
determined using high resolution respirometry, quantitative RT-PCR, NMR spectroscopy, and immunofluorescence confocal microscopy.
Results: Oxygen consumption without ATP synthase activation (leak) was significantly higher in the glycolytic muscles of Wfs1 KO mice compared to wild types.
ADP-stimulated respiration with glutamate and malate was reduced in the Wfs1-deficient cardiac as well as oxidative and glycolytic skeletal muscles.
Conclusions: Wfs1-deficiency in both cardiac and skeletal muscles results in functional alterations of energy transport from mitochondria to ATP-ases. There was a
substrate-dependent decrease in the maximal Complex I –linked respiratory capacity of the electron transport system in muscles of Wfs1 KO mice. Moreover, in
cardiac and gastrocnemius white muscles a decrease in the function of one pathway were balanced by the increase in the activity of the parallel pathway.
General significance: This work provides new insights to the muscle involvement at early stages of metabolic syndrome like WS as well as developing glucose
intolerance.
1. Introduction
1.1. Wolfram syndrome as a metabolic syndrome simultaneously affecting
multiple tissues
Wolfram syndrome (WS) also known as DIDMOAD is an autosomal
recessive disorder, caused by mutations in the WFS1 gene which encodes
for the protein wolframin [1–3]. It is a multi-targeting disease, having
influence on a number of organ systems simultaneously, and causes neu-
ronal degeneration, ataxia and alterations in the performance of cardiac
and skeletal muscles [4,5]. The first symptoms of WS are diabetes mellitus
(mean age of onset 6 years) and optic atrophy (mean onset at 11 years),
followed by diabetes insipidus and deafness. WS is a rare but probably
underdiagnosed condition; for example, in a study of 589 diabetic patients
in Lebanon 31 new WS cases were found [6].
The Wfs1 gene product wolframin is a transmembrane protein lo-
calized in the membrane of the endoplasmic reticulum (ER) [7,8]. The
exact cellular role of wolframin is still under debate. Most current
studies report that wolframin directly or indirectly regulates Ca2+
homeostasis and has an influence on the ER stress response [9–13].
Other studies have additionally demonstrated that wolframin partici-
pates in the Mitochondria-Associated ER Membrane (MAM) formation
and Ca2+ transport between mitochondria and ER [5,14].
It has been suggested that the development of glucose intolerance in
Wfs1 KO mice and WS patients is related to the insufficient insulin
secretion which, in turn, is caused by the progressive loss of pancreatic
β-cells due to alterations in cellular Ca2+ signaling [15] and increased
ER stress response with the activation of Unfolded Protein Response
(UPR) pathways [16–19]. The intracellular mechanisms for progressive
loss of the β-cells and neurodegeneration in Wfs1-deficient animals
could be similar. A recent study of mitochondrial function of Wfs1-
deficient primary rat neuronal cultures revealed that these cells have
ER stress, disturbed calcium homeostasis which in turn affects mi-
tochondrial fusion and fission dynamics, decreased mitochondrial
membrane potential and cellular ATP content [14]. At the same time,
however, the levels of wolframin are high in the cardiac, skeletal
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muscles, lungs and brown adipose tissue in WT animals, no UPR al-
terations have been detected in these tissues of Wfs1-deficient mice
[17]. Furthermore, compared to changes in the pancreas and neurons
that are apparent relatively early in the disease process, functional al-
terations in the lung and heart tissue emerge later, if at all in WS pa-
tients [20,21]. Therefore, the study of cardiac and skeletal muscles of
Wfs1 KO animals could be a valuable model to better understand the
function of the wolframin, but also diabetes and metabolic syndrome
mechanisms in these tissues as well as clarify why these cells are not
affected by Wfs1-deficiency related progressive degradation as it occurs
in the pancreatic β-cells and neurons. Currently, the pathways of the
differential effects of wolframin deficiency on different organs remain
unclear. Studies have demonstrated multiple interacting partners to
wolframin and several distinct theories have been proposed about the
pathways and timescale of how wolframin deficiency leads to altera-
tions in different organ systems [17,22–25].
Several lines of evidence indicate that WS has common features with
mitochondrial diseases. Alterations in mitochondrial DNA (mtDNA) have
been found in various tissues, including the skeletal muscles, of several WS
patients with conflicting results concerning mitochondrial respiratory
system function [26–30]. In addition, silencing of Wfs1 gene in HEK cells
has been shown to cause significant changes in the transcription of several
genes related to mitochondrial dysfunction and apoptosis [25]. However,
in a study of seven Spanish WS patients no mtDNA abnormalities were
found in blood samples [31].
Alterations in skeletal muscle energy metabolism in Wfs1-deficient
animals and in WS-patients are poorly described. Human muscles
comprise approximately 40% of the body mass. Skeletal muscles con-
tribute significantly to basal energy metabolism and serve as storage for
important substrates such as amino acids and carbohydrates. In addi-
tion, skeletal muscles are responsible for a great majority of insulin-
mediated glucose uptake [32]. During hyperglycemia, muscles are the
main tissue responsible for non-insulin mediated glucose uptake.
Therefore, disruptions of glucose metabolism, that are associated with
WS, could also be present in skeletal muscles.
Recently, there have been some descriptions of heart diseases
among WS patients, mostly due to structural alterations [6,33,34]. In a
study of Lebanese population, out of the 31 WS patients, 5 cases with
cardiac abnormalities were found [6], which is significantly higher than
in normal population. At the cellular level, Cagalinec et al. (2019) de-
scribed altered Ca2+ metabolism in the cardiomyocytes of the Wfs1-
deficient rats. They found that myocytes of the left ventricle had in-
creased contractility (both amplitude and duration of the contraction)
due to the prolonged cytosolic calcium transients. The authors proposed
that this is caused by the upregulation of RyR2 receptors which is re-
lated to the wolframin deficiency [23]. Furthermore, sinus tachycardia
and atrial and ventricular arrhythmias have been reported in some
patients in an extensive case study of WS patients [35].
To fully understand the function of wolframin, it is important to
clarify the mechanisms of varying offset of the disease in different tis-
sues; describe the alterations in skeletal and cardiac muscles in Wfs1
deficiency and determine the mechanisms by which muscles are less
affected compared to pancreatic β-cells and neurons even though Wfs1
gene is highly expressed in the heart. As described above, there is ample
evidence that wolframin influences the mitochondrial metabolism ei-
ther directly or indirectly through altered ER, Ca2+ homeostasis and
MAM. The study of oxidative and glycolytic muscles in Wfs1 KO mice
enables to estimate the extent of the alterations in the bioenergetic
profile in muscles with wolframin deficiency.
1.2. Regulation of energy metabolism in muscle tissues
As the energy demand of the oxidative skeletal muscles is perma-
nent but intermittent in intensity, the performance and flexible reg-
ulation of energy metabolism is crucial for muscle function. In oxidative
skeletal and cardiac muscle cells the oxidative phosphorylation
(OXPHOS) in mitochondria is the main energy source. Therefore, al-
terations in OXPHOS and transport of high-energy compounds to
ATPases have a direct influence on the tissue performance. In muscle
cells, the phenomenon called “macromolecular crowding”, i.e. high
concentrations of macromolecules in the cells, results in extensive dif-
fusion restrictions for metabolites [36,37]. Thus, despite the seemingly
close proximity of mitochondria and ATPases, specific phosphotransfer
networks are needed for the effective energy transfer from the ATP-
generating sites (mainly mitochondrial matrix) to the ATP-utilizing
locations (cytosol, myofibrils) [38]. A key link in high-energy phos-
phate transport system is the supercomplex Mitochondrial Interacto-
some (MI) (Fig. 1) that consists of ATP Synthasome (electron transport
system, ATP-synthase and inorganic phosphate carrier), Adenine Nu-
cleotide Translocase (ANT), mitochondrial creatine kinase (MtCK) and
mitochondrial voltage dependent anion channel (VDAC) [39,40]. The
movement of the adenine nucleotides through outer mitochondrial
membrane (OMM) is impeded due to the functional interactions of
VDAC with specific proteins including hexokinase (HK), beta-tubulin
component of free αβ-tubulin heterodimer and other cytoskeletal
components such as plectin [41–44]. However, there are no restrictions
for the transfer of creatine (Cr) and phosphocreatine (PCr) through the
VDAC, so the cytosolic and mitochondrial creatine kinase (CK) isoforms
create an opportunity for facilitated energy transport without ADP and
ATP free diffusion into the cytoplasm (Fig. 1). In the adenylate kinase
(AK) pathway, the mitochondrial AK2 isoform, present in the inter-
membrane space, facilitates both production and export of ATP by
mitochondria. In turn, the cytosolic AK1 isoform, through sequential
phosphotransfers, is responsible for the transmission of ATP and the
maintenance of the ATP/ADP ratio at ATP-utilization sites [38].
Moreover, compartmentalization of high-energy phosphate carriers
between cellular micro-compartments ensures more efficient energy
transfer compared to ATP/ADP free diffusion in the cytoplasm [45,46].
In the inner mitochondrial membrane (IMM) an electron transport
system (ETS), consisting of four complexes, creates the proton gradient
to drive ATP synthase. The contribution of each ETS complex to OX-
PHOS depends on the tissue type; activities of the complexes change
during development and aging but alterations in ETS function could be
also a sign of disease. For example, in cancer cells there is an increase in
Complex II (CII)-linked oxygen consumption rate in comparison with
corresponding healthy tissue [47–49].
The role of MI supercomplex together with CK and AK phospho-
transfer pathways is to increase the efficiency of the ATP synthesis by
the generation of two circuits: (1) transport of the energy to ATPases
and (2) quick metabolic feedback signaling (information flux in the
form of ADP) back toward mitochondria to fulfill the energy require-
ment of the cell. Alterations in MI and energy transfer pathways have a
direct influence on the muscle performance.
In this study we aimed to assess whether mitochondrial function is
impaired in the developing glucose intolerance in Wfs1 KO mice. Using
permeabilized muscle fibers, we measured the oxygen consumption rate
of ETS with two different protocols, recorded the ADP-dependency of
respiration with and without creatine, evaluated the contribution of AK
and CK energy transfer pathway, and the role of HK to regulate the
cellular respiration. We additionally assessed the levels of metabolites,
structural integrity of the cytoskeleton and the location of cytoskeletal
proteins relative to mitochondria using 1H NMR and immuno-
fluorescent confocal microscopy. To our knowledge this is a first study
to show functional alterations in intracellular energy transfer networks
in the cardiac and skeletal muscles of Wfs1 KO animals.
2. Methods
2.1. Laboratory animals and chemicals
In all experiments the wild type (WT) male mice and their Wfs1-
deficient male littermates (age 4–6months) with 129S6/SvEvTac and
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C57BL/6 mixed genetic background were used. Wfs1-deficient mice
were generated by replacing most of the coding region of the Wfs1 gene
as previously described [50]. Breeding and genotyping of the mice were
performed at the Laboratory Animal Centre of the Institute of Biome-
dicine and Translational Medicine, University of Tartu. The mice were
housed under standard laboratory conditions (at constant temperature
22 °C and a 12:12 h light/dark cycle with free access to food and water)
in the vivarium of the Department of Chemistry and Biotechnology,
Tallinn University of Technology. Animal experiments were approved
by the Estonian National Board of Animal Experiments in accordance
with the European Communities Directive (86/609/EEC).
Only ultra-pure chemicals suitable for molecular biology and work
with cell cultures were used in experiments. All chemicals were pur-
chased from Fluka and Sigma-Aldrich (Saint Louis, MO, USA).
2.2. Preparation of skinned muscle fibers
For fiber preparation animals were anaesthetized by intraperitoneal
injection of ketamine (75mg/kg) and dexmedetomidine (1mg/kg),
decapitated and skinned fibers were prepared from the heart, m. soleus,
m. gastrocnemius white (GW) and M. rectus femoris (RF) according to the
methods described previously [51]. In order to study the regulation of
mitochondrial respiration in muscle fibers, the cells' sarcolemma was
permeabilized by saponin treatment (50μg/mL) for 30min keeping the
mitochondrial membranes intact. Skinned fibers were washed in Mi-
tomedium B solution: (EGTA (0.5mM), MgCl2.6H₂O (3.0 mM), K-lac-
tobionate (60mM), KH2PO4 (3.0mM), taurine (20mM), HEPES
(20mM), sucrose (110mM), dithiothreitol (DTT, 0.5 mM), bovine
serum albumin (BSA, 5mg/mL) at pH 7.1 supplemented with leupeptin
(1 μM) for the protection of cytoskeletal proteins from lysosomal pro-
teolysis and kept in the same solution at 4 °C until used for experiments.
2.3. Measurements of oxygen consumption
All experimental measurements of oxygen consumption were de-
termined by a high-resolution respirometry instrument Oxygraph-2 K
(OROBOROS Instruments, Innsbruck, Austria). Measurements were
carried out at 25 °C in the Mitomedium B solution [51], supplemented
with BSA (5mg/mL) under continuous magnetic stirring. The permea-





























































Fig. 1. Regulation of energy metabolism of striated muscle tissues
Oxidative muscle cells are divided into functional sections called Intracellular Energetic Units (ICEU) where mitochondria are in fixed position between the T-tubules
in respect of myofibrils. Movement of the adenine nucleotides through outer mitochondrial membrane (OMM) voltage dependent anion channel (VDAC) is impeded
due to the functional interactions of VDAC with cytoskeletal protein(s). However, there are no restrictions for movement of creatine (Cr) and phosphocreatine (PCr),
so the cytosolic and mitochondrial creatine kinase (CK) isoforms create a circuit for facilitated energy transport without ADP and ATP free diffusion into the
cytoplasm. This transport is regulated by supercomplex Mitochondrial Interactosome consisting of ATP Synthase, Adenine Nucleotide Translocase (ANT), mi-
tochondrial CK (MtCK) and VDAC. MtCK transfers phosphate group from ATP to Cr. Produced PCr is moving toward ATPases via CK pathway and ADP is transported
directly back to ATP- synthase via ANT. In the adenylate kinase (AK) pathway the mitochondrial AK2 isoform, present in the intermembrane space, facilitates both
production and export of ATP by mitochondria. In turn, the cytosolic AK1 isoform, through sequential phosphotransfers, is responsible for the transmission of ATP
and maintenance of the ATP/ADP ratio at the ATP-utilization sites. (Modified from [44])
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with respiration media (Mitomedium B solution) supplemented with
0.2 μM free Ca2+ and respiratory substrates according to the protocol.
The measured oxygen consumption rates are presented as nmol O2/min
per mg dry weight.
2.3.1. Measurement of oxygen consumption kinetics
The apparent affinity of mitochondria to exogenous ADP (Km(ADP))
characterizes intracellular diffusion restrictions for ADP and varies
significantly between different cell types. These differences are caused
by specific structural and functional organization of cells' energy me-
tabolism [52,53]. In these experiments glutamate (G, 5mM) and malate
(M, 2mM) were used as respiratory substrates. In order to determine
the kinetic constants of exogenous ADP stimulated respiration, the
oxygen consumption rates with cumulative addition of ADP was mea-
sured. From these data the Km(ADP) values and maximal respiration
rates (Vmax) were calculated using Michaelis-Menten equation. In this
study we determined Km(ADP) value for oxidative m. soleus and heart
muscles in parallel with and without activated CK pathway; Km(ADP)
for glycolytic RF and GW muscles was determined without creatine. If a
Km(ADP) in the presence of creatine is significantly lower than the
corresponding value without creatine, there exists an effective func-
tional coupling of OXPHOS to CK pathway [39,52,54].
2.3.2. Determination of the coupled state of mitochondrial creatine kinase
In order to measure energy flux through CK pathway, the pyruvate
kinase/phosphoenol pyruvate (PK/PEP) system was added to trap ex-
tramitochondrial ADP. In these conditions we measure only the
OXPHOS activated by intramitochondrial ADP/ATP and directly con-
nected with the CK system [39,52,54]. The respiratory solution was
supplemented with the following substrates: G+M with addition of
PEP (5mM). After addition of MgATP (2mM) to activate ATPases, the
injected PK (10 IU/mL) activates PK/PEP system. While the PK/PEP
system rephosphorylates the ADP produced by cytosolic ATPases, the
backflow of the ADP to mitochondria is smaller, and the oxygen con-
sumption rate by the OXPHOS inside the mitochondria decreases.
Thereafter, creatine was added stepwise until saturation was reached
and the maximal respiration rate (VCr) was detected.
2.3.3. Estimation the role of cytosolic and mitochondrial adenylate kinase
For this experiment the respiratory solution was supplemented with
respiratory substrates G+M with addition of PEP (5mM). In order to
assess the influence of the AK system on the mitochondrial respiration
and to distinguish the mitochondrial AK2-dependent respiration rate
from the respiration stimulated by the cytosolic AK1, we first added
MgATP (2mM) to activate ATPases and induce maximal endogenous
ADP production. Thereafter, AMP (2mM) was added in order to acti-
vate the AK reaction coupled with OXPHOS, involving AK1 and AK2
and to register the maximal AMP stimulated respiration (VAMP).
Meanwhile, injection of PK decreases the respiration to the level of
coupled reaction between AK2 and ANT inside mitochondria which is
demonstrated by VPK. In order to determine the proportion of respira-
tion independent of AK, the AK inhibitor diadenosine pentaphosphate
(AP5A) was used (VAP5A).
The AK functional coupling with OXPHOS is represented as AK
index (IAK) and was calculated as IAK= (VAMP – VAP5A)/VAP5A. The
AK1 portion of the AK-dependent respiration (IAK1) was calculated as
IAK1= ((VAMP – VPK)) / (VAMP – VAP5A))*100% [55].
2.3.4. Coupling of hexokinases to OXPHOS
Hexokinases catalyze the first and irreversible step of glycolysis,
phosphorylating glucose to glucose-6-phosphate (G6P). In order to
measure the ability of HK to stimulate OXPHOS by locally generated
ADP in the vicinity of VDAC channel, MgATP was added into the
medium supplemented with respiratory substrates G+M. The addition
of MgATP (0.1 mM and 2mM in case of glycolytic and oxidative
muscle, respectively) allowed achieving maximal stimulation of
mitochondria with endogenous ADP produced by ATPases.
Supplementation of glucose (10mM) activates the HK reaction and
VGLUC could be registered. Then, the maximal ADP-dependent respira-
tion rate (VADP) is achieved in the presence of ADP (2mM). Addition of
cytochrome c (10 μM) allowed controlling the quality of the OMM. The
glucose index (GI) was calculated as (VGLUC – VATP) / (VADP)*100%
[52].
2.3.5. Substrate-uncoupler-inhibitor titration (SUIT) protocols
In order to reconstitute the TCA cycle function and sequential se-
parate branches of mitochondrial pathways for OXPHOS analysis a
modified SUIT protocols were used [56]. Permeabilized muscle fibers
were added into a chamber where respiration was observed in Mito-
medium B solution.
Protocol 1. Titration of substrates, uncouplers and inhibitors were
added in sequence. Malate and pyruvate (P, 5mM), providing electrons
for Complex I (CI) were injected into the chamber to register basal leak
oxygen consumption in the absence of adenylates. The addition of ADP
(2mM) stimulated respiration and represented coupled work of CI and
phosphorylation system. In order to detect substrates' preference and
determine limiting factor for CI, G (5mM) was added into the chamber
and the maximal CI-dependent respiration rate was registered.
Succinate (S) supports electron transport through CII, thus addition of S
(10mM) allowed determining the ADP-dependent respiration when
electrons are fed to the ETS via CI and CII. Subsequent addition of ADP
(final concentration of 5mM) stimulated respiration and allowed to
control the limitations in the efficiency of ATP synthase [57]. The
theoretical maximal capacity of the ETS was evaluated with titration of
uncoupler carbonyl cyanide-4-(trifluoromethoxy)phenylhydrazone
(FCCP) until saturation of respiration was reached. Subsequent inhibi-
tion of CI by rotenone (2.5 μM) allowed to determine the CII-linked
electron transfer (ET) capacity. Inhibition of Complex III (CIII) by an-
timycin A (10 μM) allowed to determine the residual oxygen con-
sumption. Addition of N,N,N′,N′-tetramethyl-p-phenylenediamine
(TMPD; 1mM) demonstrates maximal capacity of complex IV (CIV).
Addition of NaCN (1mM) inhibited cytochrome oxidase (COX) and
blocked electron transport, as a result it allowed to detect residual
oxygen consumption due to TMPD oxidation reactions [56].
Protocol 2. In the second protocol the contribution of CI and CII to
oxygen consumption in skinned muscle fibers was evaluated. First, the
mitochondrial respiration rates under nonphosphorylating conditions
(basal respiration rate (V0)) with G and M in the oxygraphic chamber
were registered. Second, after addition of 2mM ADP the maximum rate
of NADH-linked ADP-dependent respiration was detected; subse-
quently, CI was inhibited by rotenone (5 μM). Last, the substrate S
(10mM) was added to activate ETS CII-dependent respiration. From
these results the ratio of CII versus CI can be calculated.
2.4. Immunofluorescence confocal microscopy
To examine cell architecture and colocalization of mitochondrial
VDAC with βII-tubulin and plectin in WT and Wfs1 KO mice fibers,
confocal microscopy imaging was used. The tissue samples (fibers) were
washed with Ca/Mg free phosphate buffered saline (PBS) and fixed in
4% paraformaldehyde (PFA) at 37 °C for 15min. After washing step
with PBS, the samples were treated with Antigen Retrieval Buffer (Tris
(100mM), urea (5%), pH 9.5) at 95 °C for 5min. The fibers were wa-
shed with PBS and permeabilized with 1% Triton X-100 at room tem-
perature for 15min, washed again with PBS and blocked in PBS solu-
tion containing 2% fatty acid free BSA for 1 h at room temperature. In
order to detect VDAC with βII-tubulin the samples were incubated at
4 °C overnight with primary antibodies: goat polyclonal antibodies for
VDAC (sc-32,064) at 1:50 or 1:70 and rabbit monoclonal antibody for
βII-tubulin (ab170931) at 1:200 or 1:250. After incubation, the samples
were washed with 2% BSA solution and secondary antibodies were used
for visualization (Cy3 donkey anti-goat IgG (Abcam, ab97115) at 1:200
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and donkey anti-rabbit IgG (Alexa Fluor 488, ab150073) at 1:200). To
detect and visualize VDAC with plectin the following primary and
secondary antibodies were used: rabbit polyclonal antibodies for VDAC
(kindly provided by Catherine Brenner) at 1:200, guinea pig polyclonal
antibodies for plectin (PROGEN, GP21) at 1:250 and goat anti-rabbit
IgG (DyLight 488, ab96895) at 1:200, goat anti-guinea pig IgG (Alexa
Fluor 647, ab150187) at 1:250. Samples were incubated with secondary
antibodies as described above at room temperature for 2 h and then
washed with 2% BSA solution, PBS and finally with deionized water.
The samples were treated with ProLong Gold antifade reagent (Life
Technologies) supplemented with 4′,6-diamidino-2-phenylindole dihy-
drochloride (DAPI, Molecular Probes) for visualizing the cell nucleus
and deposited on glass coverslips for observation with confocal mi-
croscope (Olympus FluoView FV 10i-W).
2.5. 1H NMR spectroscopy
For NMR analysis, heart muscle was frozen and powdered in liquid
nitrogen. The powder was weighted and subjected to a methanol:water
(2:1) extraction. Overnight lyophilized sample material was recon-
stituted in 0.5mL of phosphate buffer (100mM, pH 7.4). Thereafter, the
sample was mixed with 4,4-dimethyl-4-silapentane-1-sulfonic acid
(DSS, 1mM)) in D₂O standard solution in ratio 9:1. The liquid amounts
were determined gravimetrically. All experiments were performed at
room temperature (25 °C) in 256 scans on a Bruker Avance III
800.13MHz spectrometer equipped with a triple resonance inversed
(TXI) probe. Chemical shifts were referenced and all concentrations
calculated as a fold change compared to the DSS (0.1mM) internal
standard signal.
2.6. Determination of enzymatic activities
Pieces of muscles were snap frozen in liquid nitrogen and stored at
−80 °C. The samples were allowed to thaw at 0 °C and homogenized in
the medium containing the following: EDTA (1mM), DTT (1mM),
glucose (10mM), MgCl2 (5mM), HEPES (5mM), Triton X-100(0.1%)
and leupeptin (5μg/mL), at pH 8 (maintained by NaOH) by Ultra-
Turrax T25 homogenizer (IKA, Germany) on ice.
After homogenization the homogenates were left on ice for 1h to
allow complete extraction of the enzymes. Measurement of HK activity
was performed using a spectrophotometer Lambda 900 (Perkin Elmer,
U.S.) in solution containing Tris–HCl (50mM), glucose (20mM), DTT
(0.3) mM, NADP (0.6mM), MgATP (2mM), glucose-6-phosphate de-
hydrogenase (G6PD) (2 IU/mL), pH 7.6, adjusted at 25 °C. The rate of
NADPH formation was monitored after addition of homogenate at
340 nm [58]. For CK activity measurements solution containing glucose
(20mM), AMP (20mM), DTT (0.3mM), magnesium acetate (3mM),
MgADP (1mM), NADP (1mM), Tris-HCl (50mM) (pH 7.4, 25 °C), HK
(2IU/mL), and G6PD (2IU/mL) at 25 °C was used. After stabilization of
the optical density, the reaction was started by adding 20mM PCr and
the rate of NADPH formation was registered [59]. AK activity
measurements were performed in solution containing Tris-HCl (20mM)
(pH 8, at 30 °C), KCl (15mM), DTT (0.33mM), NADH (0.24mM), PEP
(0.8mM), ATP (1mM), lactate dehydrogenase (3 IU/mL) and PK 6 (IU/
mL). After registration of the basal ATPase activity, AMP (1.3mM) was
added and from the following changes in NADH oxidation rates at
340nm, the AK activity was calculated [59].
2.7. Gene expression study
Total RNA was isolated by using the RNeasy Mini Kit (Qiagen).
Genomic DNA wipeout and reverse transcription was performed by
using Quantitect® Reverse Transcription Kit (Qiagen) according to
manufacturer's protocol (Quantitect® Reverese Transcription
Handbook, 2005). Real-time PCR amplification was carried out with
mouse gene-specific primers (Proligo, France and Oligomer OY,
Finland, Table 1) using QuantiTect SYBR Green PCR Kit (Qiagen, Ger-
many). The process of collecting fluorescence data during PCR was
performed by StepOnePlus™ real-Time PCR Instrument (Applied Bio-
systems, USA). The relative target quantity in samples was determined
by the comparative threshold cycle (ΔCт, ΔΔCт) method [60]. Mea-
surements were normalized to multiple endogenous control genes:
ACTB, B2M or HPRT1. The relative quantity of target in each sample
was assessed by comparing normalized target quantity in each sample
to normalized target quantity in the reference sample.
2.8. Statistical analysis
Results are expressed as the mean ± standard error of the mean
(SEM). To determine statistical significance between age groups, one-
way analysis of variance (ANOVA) test was performed and p va-
lues< .05 were considered significant.
The proton NMR spectra of all samples (one sample corresponds to
one mouse) were subjected to principal component analysis on
Mestrenova version 12.
3. Results
3.1. Alterations in kinetic profile and substrate preferences (Km(ADP) and
SUIT protocols)
In skeletal and cardiac muscles a contiguous energy supply for
ATPases in myofibrils and ion channels is crucial for muscle work. In
oxidative muscles the predominant site of the ATP synthesis is the
mitochondrion where proton gradient is formed by ETS and the ADP
phosphorylation is regulated by MI supercomplex.
The capability of Wfs1 KO and WT muscle cell mitochondria to
generate ATP was followed using oxygraphic measurements with (1)
SUIT (substrate-uncoupler-inhibitor-titration) protocol [56], (2) sub-
strate-inhibitor protocol to determine the individual capacity of CI- and
CII–linked ET, and (3) classical ADP-titration protocol to determine the
kinetic constants like apparent Michaelis-Menten constant for ADP (Km
(ADP)) and the maximal respiration rate (Vmax). With these protocols
the respiration linked to different pathways of the ETS can be followed
simultaneously to the preference of the pathways to specific substrates.
In the SUIT protocol, P+M were first inserted as CI–linked sub-
strates, and thereafter ADP was added to activate OXPHOS in mi-
tochondria (VADP). Subsequently, glutamate was injected to detect the
effect of different CI-linked substrates on OXPHOS (VGLUT). We ob-
served that the Leak respiration (oxygen consumption without adeny-
lates) in these conditions was statistically higher in Wfs1-deficient so-
leus, RF and GW muscles but not in the cardiac muscle (Fig. 2A).
In the presence of P+M and ADP, the CI–linked OXPHOS was
significantly different only in GW muscle where both the VADP and
VGLUT values were lower in Wfs1 KO animals compared to WT
(Table 2). After addition of S (CII – linked substrate) the increase in
respiration rate was significantly higher in Wfs1 KO mice GW muscle in
Table 1
Primers for real-time PCR analysis.











F: forward; R: reverse.
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comparison with WT (Table 2). Similar tendency was observed in the
other glycolytic muscle, RF but the changes were not statistically sig-
nificant (data not shown). With substrate-inhibitor protocol, where
after registering CI – dependent oxygen consumption rate, CI was in-
hibited with rotenone and then S was added, an increase in the ratio of
CII-linked to CI–dependent respiration was detected in the soleus and
RF muscles of Wfs1 KO compared to WT (Table 3). These results in-
dicate a shift from CI- to CII-induced respiration in skeletal muscles of
Wfs1 KO animals as a characteristic of pathological alterations.
We observed interesting shifts in substrate preferences in our ex-
periments. As described above, with M+P as CI–linked substrates, the
basal Leak respiration was significantly higher in Wfs1-deficient soleus,
RF and GW muscles but not in the cardiac muscle (Fig. 2A). In the
second set of experiments measuring oxygen consumption kinetics we
used G+M as CI–linked substrates and detected a higher Leak re-
spiration in glycolytic RF and GW muscles of Wfs1 KO mice compared
to WT (Fig. 2B). In parallel, the maximal CI–linked respiration rate in
the presence of P+M was significantly lower only in GW in Wfs1 KO
mice (Table 2), while with G+M as CI–linked substrates the decrease
in oxygen consumption was statistically significant in all studied mus-
cles of Wfs1 KO mice compared to WT (Fig. 3).
In the measurements of oxygen consumption kinetics, using G+M
as CI-linked substrates, exogenous ADP was added stepwise until the
maximal respiration rate was achieved. In these conditions, as men-
tioned above, the maximal oxygen consumption rate was significantly
(a)
(b)
Fig. 2. Determination of the Leak respiration with different complex I
substrates
Basal leak respiration (oxygen consumption rate without adenylates) in the
heart, m. soleus, m. rectus femoris (RF) and m. gastrocnemius white (GW) fibers of
Wfs1 KO and wild type (WT) mice with (a) pyruvate (P, 5mM) and malate (M,
2mM) and (b) glutamate (G, 5mM) and M as substrates. Respiration rates are
represented as nmol O2*min-1*mg dw-1; *p< 0.05, ** p<0.01, ***p<0.001;
n=6-10
Table 2
Oxygen consumption rates (V) in the GW muscles of Wfs1-deficient (Wfs1 KO)
and wild-type (WT) mice as measured according to the substrate-uncoupler-
inhibitor titration protocol. The VSucc-VGlut represents increase in the respira-
tion rate due to the addition of the CII-linked substrate of the ETS.
WT Wfs1 KO
ADP 2mM 1.57 ± 0.15 0.68 ± 0.22⁎⁎
Glutamate 5mM 1.84 ± 0.14 0.86 ± 0.19⁎⁎
Succinate 10mM 2.48 ± 0.22 2.48 ± 0.25
ADP 5mM 2.70 ± 0.27 2.76 ± 0.27
FCCP 2.68 ± 0.26 2.70 ± 0.28
Rotenone 2.5 μM 1.55 ± 0.22 1.75 ± 0.27
Antimycin A 10 μM 0.26 ± 0.04 0.26 ± 0.16
Complex IV 5.42 ± 0.87 4.01 ± 0.37
VSucc-VGlut 0.64 ± 0.26 1.63 ± 0.28**
Values are represented as the mean ± SEM, ⁎⁎ p < .01, (n= 6–10) compared
to WT.
Table 3
Relative ratio of CII- versus CI–linked oxygen consumption rate in electron
transport system of Wfs1-deficient (Wfs1 KO) and wild-type (WT) mice muscles.
Type of muscle V(CII)/V(CI)
WT Wfs1 KO
Heart 1.31 ± 0.12 1.00 ± 0.05
Soleus 0.77 ± 0.05 1.44 ± 0.07⁎⁎⁎
Rectus femoris 0.56 ± 0.01 0.86 ± 0.08⁎
Values are represented as the mean ± SEM. ⁎ p < .05, ⁎⁎⁎ p < .001 compared
to wild type (n=6–10).
Fig. 3. Maximal oxygen consumption rates with glutamate and malate
Maximal oxygen consumption rates (Vmax) in Wfs1KO and wild type (WT) mice
heart, m. soleus, m. rectus femoris (RF) and m. gastrocnemius white (GW) fibers
with glutamate (G, 5mM) and malate (M, 2mM) as substrates. Vmax is de-
termined from the measurements for Michaelis-Menten coefficient calculation.
Respiration rates are represented as nmol O2*min-1*mg dw-1; ***p< 0.001;
n=6-10
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lower in all measured Wfs1 KO mice muscle fibers compared to WT
animals (Fig. 3). In parallel, Km(ADP) values did not show prominent
kinetic differences between Wfs1 KO and WT skeletal muscle fibers
(Table 4). However in the cardiac muscle fibers we detected a decrease
in the Km(ADP) value (100 versus 50 μM ADP in WT and Wfs1 KO
respectively), but in the presence of Cr, mimicking better physiological
conditions, Km(ADP) values in the study group and WT animals were
similar.
In conclusion, the results of oxygraphic measurements, character-
izing ETS revealed increased Leak respiration in both GW and RF gly-
colytic skeletal muscles in the presence of M+G, as well as increased
Leak respiration in the soleus, RF and GW muscle fibers in the presence
of M+P. The maximal CI-dependent oxygen consumption rate in the
presence of G+M decreased in all followed Wfs1 KO muscles com-
pared to WT. In the presence of P+M, a decrease in the CI-linked ADP-
stimulated respiration rate was detectable only in Wfs1 KO GW muscle
compared to WT. These results indicate some alterations in glutamate
metabolism, having no influence on the metabolism of pyruvate. In
addition, in GW muscle the CII-linked respiration was significantly
higher in Wfs1 KO muscle compared to WT. A similar shift was also
detected in the soleus and RF muscles when the capacities of ETS
complexes were measured independently.
These measurements were performed in conditions where energy
transfer pathways from mitochondrion to ATPases in the cell were not
activated. To investigate how the transport of the energy from mi-
tochondrion to ATP-ases influences OXPHOS, we next investigated the
three most important systems for energy facilitation in skeletal muscles.
3.2. Energy transfer pathways
Intracellular transfer of ATP from mitochondria to ATPases is im-
peded; thus, special energy transfer pathways are essential for main-
taining steady energy balance at different ATP consumption sites in the
cell. Facilitated transport of metabolites is especially important in
oxidative muscle cells like the heart and soleus, where most of the ATP
is synthesized in mitochondria; alteration in these pathways has im-
mediate influence on the cellular metabolism as a whole. It has been
demonstrated that the main energy transport system in the oxidative
skeletal and heart muscles is the CK/PCr pathway [40,45,61], followed
by the AK pathway [38,62]. In oxidative muscle cells, one of the
manifestations of the effectiveness of the CK pathway is the increased
affinity of mitochondria toward ADP (decrease in the Km(ADP) value)
when the pathway is activated. In glycolytic GW and RF muscles the Km
(ADP) value is low because there is no impediment for the ADP/ATP
through the VDAC in the OMM. Therefore, it is not possible to de-
termine the role of CK transfer with this method in these muscles. The
effect of activation of CK pathway on Km(ADP) value was detected in
the mutant and WT soleus and WT heart muscle fibers (Table 4). The
Table 4
Michaelis-Menten constant Km(ADP) values in the muscles of Wfs1-deficient
(Wfs1 KO) and wild-type (WT) animals with (+Cr) and without (eCr) activa-
tion of creatine kinase pathway.
Km(ADP)
Type of muscle - Cr + Cr
Heart WT 101.6 ± 21.3 42.7 ± 5.0
Wfs1 KO 54.2 ± 5.2 41.4 ± 3.0
Soleus WT 463 ± 78.9 62.4 ± 15.4
Wfs1 KO 482 ± 78.2 50.3 ± 16.8
RF WT 6.45 ± 0,64 –
Wfs1 KO 18.99 ± 3.15 –
GW WT 10.36 ± 1.02 –
Wfs1 KO 12.64 ± 2.29 –
Values are represented as nmolO2*min−1*mg dw−1, means ± SEM are shown




Fig. 4. Quantification of functional coupling between OXPHOS and energy
transfer pathways
(a) Oxygen consumption rates measured with the maximal activation of the
creatine kinase pathway. Respiration rates are represented in nmol O2*min-
1*mg dw-1.
(b) Functional coupling of oxygen consumption with adenylate kinase (AK)
pathway is represented as AK index (IAK) calculated as IAK = (VAMP – VAP5A)/
VAP5A where VAMP is oxygen consumption rate at the maximal activation of AK
system and VAP5A in the presence of AK inhibitor.
(c) Functional coupling of hexokinase (HK) to OXPHOS. The glucose index (GI)
was calculated as (VGLUC – VATP) / (VADP)*100% where (VGLUC – VATP) is the
increase in the oxygen consumption rate in response to addition of 10mM
glucose and VADP is the respiration rate in the presence of 2mM ADP; *p< 0.05,
** p<0.01, ***p< 0.001; n=6-10
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Km(ADP) value in the heart fibers of Wfs1 KO animals was already
lower without Cr, so we observed no further significant decrease as a
response to the CK pathway activation (Table 4).
In the second protocol we used PK/PEP system for trapping all ADP
generated by ATPases. Under these conditions, the registered oxygen
consumption is directly dependent only on the ADP/ATP circulation
incorporated in the MI and CK transfer system. The maximal Cr acti-
vated OXPHOS rate (VCr) in Wfs1 KO oxidative muscle (heart and so-
leus) fibers was decreased compared to WT and the alteration was more
pronounced in the heart muscle (Fig. 4A). In contrast, in glycolytic GW
the VCr was higher in fibers of Wfs1 KO mice than in WT. There was
some decrease in VCr in RF muscle but the change was not significant
(Fig. 4A).
In parallel, the total CK enzyme activities of in the wolframin-de-
ficient soleus and RF muscle were ~2 times decreased but there were no
differences detected in the heart and GW compared to WT tissues
(Table 5). Recent proteomic results also showed no change of CK iso-
enzyme levels in the wolframin-deficient heart [63]. Consequently,
lower oxygen consumption rate with activated creatine kinase pathway
in Wfs1-deficient heart (Fig. 4A) could be mostly caused by the wea-
kened interaction between mitochondrial CK and ANT and thereby
impaired MI function.
Additionally, a study of the abundance of CK isoforms in RF de-
monstrated lower muscle-type CK isoform (CK-MM) mRNA level of
Wfs1-deficient mice than in their WT littermates (Table 6). As CK-MM is
known to be functionally coupled with ER Ca2+-ATPase [64], the
capability of CK-MM to phosphorylate ADP, produced by myofibrillar
or ER ATPases, can be reduced and thereby induce local ATP deficiency.
It leads to the impairment of muscle contraction and the other ER-
linked energy-consuming processes. However, here we found that the
expression of mitochondrial CK coding gene CKMT2 did not differ
significantly (p= .213) between these two groups (Table 6).
The other main energy pathway in muscle cells is AK pathway. In
Fig. 4B, the AK activation was presented as maximal AK oxygen con-
sumption relative to the oxygen consumption independent of the AK
system - AK Index (see 2.3.3. Methods). In oxidative, heart and soleus
muscles there is a significant increase in the AK Index value in the fibers
of Wfs1 KO mice compared to the WT fibers (Fig. 4B). Nevertheless, in
soleus muscle the activity measurements of the tissue homogenates
demonstrated a significant decrease in the AK activity (Table 5). This
controversy needs future study, but it could be explained by the dif-
ferent approach of the experiments. In the enzyme activity evaluation,
all the AK isoforms located in the tissue were included, while in the
presented oxygraphic measurements only the AK, connected with
transfer of high-energy phosphates from mitochondria to ATPases were
followed. In glycolytic muscles, GW and RF, no significant change was
detected in AK Index; however, we observed a trend toward decreased
AK index in both muscles. Additionally, when looking at the total AK
activity measurements, the decrease in AK activity in Wfs1 KO mice RF
muscle was statistically significant (Table 5).
In addition, we measured the relative contribution of AK isoforms to
the overall AK-related oxygen consumption flux using a protocol de-
veloped in our laboratory [52,55]. The role of cytosolic (AK1) isoform
varies from ~60% in soleus to ~80% in heart muscle (Table S1 in
supplements); however, despite some increase in the contribution of
AK1 isoform in the GW muscle Wfs1 KO mice, the differences between
Wfs1-deficient and WT mice muscles were not statistically significant.
The third investigated energy transfer system is the glycolytic
pathway. These data are represented as the glucose index (GI) calcu-
lated as the ratio of the relative increase in OXPHOS rate due to the
glucose addition to the maximal respiration rate with exogenous ADP.
The GI characterizes the functional coupling of OXPHOS with glyco-
lysis. According to our results, there are some interesting shifts in the GI
values: in the oxidative heart muscle of the Wfs1 KO animals the GI is
higher compared to WT; in the glycolytic GW muscle fibers, the nor-
mally high GI value decreases in KO animals (Fig. 4C). In parallel, the
total HK activity in heart and GW muscle of Wfs1 KO animals were
similar to wild type (Table 5).
Taking together, the alterations in the AK related oxygen con-
sumption in the cardiac and soleus muscle cells are the opposite of
those taking place with CK-related respiration (Fig. 4). Consequently, in
the oxidative muscles of Wfs1 KO animals the role of CK energy transfer
system is decreasing and at the same time, functional coupling of mi-
tochondria with AK is increasing when compared to the muscles of WT
animals. These shifts from one energy transfer pathway to the other
may indicate a compensatory mechanism in energy metabolism. As the
CK pathway activity is lower in oxidative muscle cells of Wfs1 KO an-
imals, the AK and HK pathway may help to manage the energy flow
from mitochondrion to the ATPases, especially in the cardiac muscle.
Increase in the GI value in the cardiac muscle cells is registered during
aging of the rat heart cardiomyocytes [65]. In the cardiomyocytes of
young healthy animals the GI is very low, around 1%; during aging it
increases to 8.2% at the age of 1.5 years.
3.3. H NMR studies of the heart muscle
Metabolites in tissue water soluble extracts of 4–6month mice were
determined using 1H NMR spectroscopy. The total creatine content of
KO animals was not different from that of the WT. The principal com-
ponent analysis of proton NMR spectra did not reveal any systematic
differences between the two mouse genotypes. We also calculated the
values of six abundant metabolites: glucose, lactate, alanine, glutamine,
glutamate and taurine (Supplementary Table 2). The concentrations of
these metabolites were similar as presented before by Zervou et al.
2016 [66]. We did not find any statistically significant differences be-
tween the KO and WT groups. Our results are in good accordance with
the study by Porosk et al. (2017) were they compared the heart meta-
bolome of six month old Wfs1 KO and WT mice [67]. Therefore, the
Table 5
Enzyme activities of Wfs1-deficient (Wfs1 KO) and wild-type (WT) mice mus-
cles. Values are represented as nmol*min−1*mg ww−1 (n=5–8).
Enzyme Type of muscle WT Wfs1 KO
Creatine kinase Heart 262.5 ± 32.6 304.1 ± 16.7
Soleus muscle 870.8 ± 101.4 443.3 ± 32.6 ⁎⁎
Rectus femoris
muscle
3072.1 ± 180.2 1579.2 ± 224.6 ⁎⁎⁎
Gastrocnemius
muscle
3495.4 ± 226.5 3088.1 ± 142.9
Adenylate
kinase
Heart 176.0 ± 28.5 179.8 ± 22.8
Soleus muscle 350.8 ± 18.5 196.0 ± 10.9⁎⁎⁎
Rectus femoris
muscle
399.8 ± 37.6 205.4 ± 48.9 ⁎⁎
Gastrocnemius
muscle
636.9 ± 60.8 654.8 ± 43.9
Hexokinase Heart 7.2 ± 0.5 8.0 ± 0.7
Soleus muscle 3.80 ± 0.11 3.43 ± 0.10 ⁎
Rectus femoris
muscle
1.53 ± 0.09 2.14 ± 0.18 ⁎⁎
Gastrocnemius
muscle
2.58 ± 0.12 2.85 ± 0.05
Values are represented as the means ± SEM. ⁎ p < .05, ⁎⁎ p < .01, ⁎⁎⁎
p < .001 compared to wild type.
Table 6
Relative mRNA levels of CK isoforms in M. rectus femoris of Wfs1-deficient
(Wfs1 KO) and wild-type mice (WT).
CKB CKM CKMT2
WT mice, 0.03 ± 0.01 199.0 ± 38.9 2.42 ± 0.43
Wfs1 KO mice, 0.04 ± 0.01 93.5 ± 9.5 * 3.42 ± 0.61
Values are represented as the means ± SEM. * p < .05 compared to wild type
(n=6).
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alterations in the regulation of CK pathway could be a significant sign of
functional disturbances in the cardiac muscle energy metabolism.
3.4. Structural changes - confocal microscopy
The energy metabolism regulation in the muscle cell mitochondria
is directly dependent on the functional interaction of mitochondrial
VDAC with cytoskeletal proteins, one of which is probably β-tubulin
component of the free αβ-tubulin heterodimers [41,68,69]. According
to our visual and manual observations the skeletal muscles of WFS1 KO
mice are softer and more delicate then WT muscles. However, the an-
imals have no difficulties to manage their movement in captivated/cage
conditions. We used confocal microscopy to follow if this observation is
accompanied with changes in the structure of the muscle cell. We used
antibodies for VDAC and βII-tubulin in one combination (Fig. 5) and
VDAC with plectin in another. Some alterations were detected in cal-
culated Pearson's coefficients in muscle fibers of Wfs1 KO animals
compared to WT, but these changes could not be considered as sig-
nificant in the given context. As the age of the animals in our experi-
ments was 4–6month, there is a possibility that more prominent
changes could develop later in the course of the disease.
4. Discussion
Recently, several theories about the pathways of the WS and the
possible roles of wolframin have been presented. The placement of the
wolframin in the ER membrane has been demonstrated and the in-
volvement of the protein in cell metabolism through homeostasis of
Ca2+ has found most proponents. However, several questions still re-
main unanswered. A few studies have investigated the effects of WS in
the muscle tissue, specifically in the bioenergetic metabolism. Some
patient reviews indicate that the incidences of congenital heart defects
are significantly higher among WS patients [33,34]. However, large
functional alterations have been not detected in all patients. A possible
reason for the lower number of reports about changes in the muscle
tissues in WS patients could be that more emphasis is placed on the
pathological conditions that emerge first in the disease process (e.g.
pancreatic β-cell and neuronal changes) and thus affect the life quality
in higher extent. Furthermore, as the life expectancy of the WS patients
is reduced, smaller changes in physiology may occur unnoticed. How-
ever, to understand the mechanisms and roles of the wolframin protein,
different tissues should be studied.
In this study, by studying 4–6month old Wfs1 KO and WT mice, we
detected some regulatory kinetic alterations in the apparent affinity of
exogenous ADP to mitochondrion and some decline in the colocaliza-
tion pattern between mitochondria and tubulin in soleus muscle of
Wfs1 KO mice. Therefore, we may conclude that there are no critical
structural changes in muscle cells and the functional interactions be-
tween mitochondria and cytoskeleton are generally intact. However, we
observed significant changes in several aspects of OXPHOS and in the
functional properties of the electron transport system and pathways,
transporting high energy bond to the ATPases.
With both substrate combinations used for CI–linked respiration,
increase in the Leak or basal Leak respiration was detected in the gly-
colytic muscles in Wfs1 KO compared to WT mice. This value demon-
strates oxygen consumption in the non-phosphorylating conditions, i.e.
proton leak through the IMM, across lipid bilayers without ATP-syn-
thase activation. This result indicates inefficiency of the OXPHOS
system and may be a sign of the functional changes in the IMM. These
findings are in accordance with the research of Eimre et al. (2018) [70]
Fig. 5. Evaluation of the interaction between mitochondria and tubulin
Representative colocalization (C) pattern of (A) mitochondria (marked as VDAC1 (sc32064)Cy3 - red) and (B) βII-tubulin component of the α/β tubulin hetero-
dimeres (beta2TUB (ab170931)Al488 - green) in WT (1) and Wfs1KO (2) soleus muscles. There is a tendency to decrease the colocalization between mitochondria
and tubulin; calculated Pearson's coefficients are 0.93 and 0.54 for WT and for Wfs1KO, respectively.
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as they found an increase in the Leak respiration in the RF muscle of
aged, 9–12month old mice together with increased uncoupler protein 2
mRNA levels. In addition, they found that the citrate synthase activity
and amount of ETS subunits as well as mitochondrial proteins was in-
creased in the glycolytic RF muscle, while no important alteration was
detected in oxidative cardiac and soleus muscle of Wfs1 KO compared
to WT mice. Moreover, it has been demonstrated that the basal Leak
respiration is related to the amount of ANT and other anion carrier
proteins in mitochondria [71], but not with the activity of these protein
complexes [72]. Thus, the increase in the Leak respiration could be
connected to the alterations in the IMM composition or increase in the
ANT abundance, which could be caused by an increase in the number of
MI in mitochondria as an adaptive response to the less efficient ATP
production in the Wfs1 KO animals.
In all the muscle types studied, we observed that the maximal ADP-
dependent respiration rate with G+M was lower in the Wfs1 KO an-
imals compared to WT. Interestingly, when P+M was used as CI-
linked substrate, we found no significant differences between Wfs1 KO
and WT. These results indicate that the wolframin deficiency has caused
some alterations in the cell which have influence on the glutamate but
not on the pyruvate metabolism. WS is characterized by increased ER
stress, decrease in the number of mitochondria-ER connecting sites, and
disturbances in Ca2+ homeostasis. These changes could have an influ-
ence on the activity of protein complexes regulating glutamate meta-
bolism in mitochondria such as glutamate-aspartate antiporter (AGC)
and 2-oxoglutarate-malate transporter. It has been demonstrated that
Ca2+ related alterations in AGC1 (which is also expressed in the cardiac
and skeletal muscle) is one of the causes of the autism spectrum dis-
order [73]. As the alterations in Ca2+ metabolism have also been de-
tected in WS, these changes may also have an influence on the gluta-
mate-related oxygen consumption rate here. Furthermore, in a study of
cardiac cells with induced ER stress, Prola et al. (2019) detected a de-
crease in the glutamate- and succinate- but not in pyruvate-induced
respiration. They concluded that fatty acid oxidation pathway in mi-
tochondria is down-regulated in cells with ER stress while relative
oxidation of pyruvate is increased [74]. These results are in a good
accordance with the current study as we found that the GI was in-
creased in the heart fibers of Wfs1 KO mice compared to WT.
The transport of high energy bond from mitochondria to ATPases is
a crucial part of the energy provision. Our study demonstrated that
there are several alterations in the pathways responsible for energy
trafficking. We found an important shift taking place in the heart
muscle of the Wfs1 KO mice. In healthy cardiac muscle cells the CK has
a leading role in the transport of the phosphoryl group to ATPases. In
the cardiac cells of Wfs1 KO animals the oxygen consumption rate of
the creatine stimulated respiration is decreasing, while the role of the
secondary AK pathway is increasing. Simultaneously, the functional
interaction with glycolytic enzymes, represented as the glucose index, is
higher in cardiac muscle of the Wfs1 KO animals. In glycolytic GW
muscle, a contrary shift is taking place: in WT GW muscle, high GI was
determined, but it was decreased significantly in the GW fibers of Wfs1
KO mice. In parallel, there was a significant increase in the CK
pathway–related respiration in the wolframin deficient animals. Similar
alterations in the pathway preferences are detected in the aging heart
muscle [65] and in pathological conditions such as cancer [48]. These
changes indicate possible compensatory mechanisms as a response to
altered metabolism in the muscle cells: a decrease in the CK pathway is
balanced by an increase in the AK system in the heart muscle. Similarly,
in GW muscle a shift from glycolytic to CK pathway is taking place.
Using 1H NMR, we detected no significant alterations in the meta-
bolites profile of Wfs1 KO animals. This relative stability may be
achieved due to the compensatory mechanism in the energy transfer
pathways which enable to continue the muscle work at lower effi-
ciency. We speculate that the problems might arise during in vivo
conditions when the workload of the muscle has to be increased.
The results of our study indicate adaptations in the bioenergetic
metabolism of the muscles to the alterations caused by the Wfs1 defi-
ciency. We observed no crucial structural alterations, but clear func-
tional changes in the MI and energy transport were detected. It was
visible that in some muscles a decrease in the one pathway was ba-
lanced by the increase in the activity of parallel pathway. There was no
direct decrease in the CI–linked ET capacity, but rather change in the
substrate preference profile, which might have been caused by the al-
terations connected with ER stress. These results are in accordance with
the study of skeletal muscle of young adults with type I diabetes, where
no changes in mitochondrial content or distribution have been de-
tected, but mitochondrial oxidative capacity has been shown to de-
crease [75].
It has been demonstrated that wolframin is highly expressed in the
cardiac as well as in the skeletal muscles. There are some reports of
atrial and ventricular arrhythmias and sinus tachycardia in the later
stages of WS [35]; however, the extent of the impairment is sig-
nificantly smaller in comparison with the ones that emerge earlier in
the neurons and pancreatic β-cells. Adaptations in muscle tissue as a
response to the wolframin deficiency, detected in our study, could ex-
plain the contradiction. Yet, as the WS-accompanied alterations in
oxidative muscle cells are not essential, the role of wolframin might be
more complex and include additional functions regulating Ca2+
homeostasis.
In sum, WS is a metabolic disease with complicated diagnostics.
Several cases have been described where patients with WS are mis-
diagnosed and treated for diabetes for years [33,34]. Better mechanistic
understanding of wolframin functions could enable the development of
methods for earlier diagnosis of WS, and for possible treatments in
order to postpone the manifestations of the disease such as optical
nerve degradation or diabetes. Our results demonstrate that WS is a
mitochondrial disease and monitoring functional alterations in striated
muscle bioenergetics could be considered as one of the directions for
the better understanding of wolframin functions and for developing
improved diagnostic methods for WS.
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